To compare and evaluate the effect of topical Cyclosporine A eye drops and topical Interferon alpha 2b eye drops in preventing recurrence of pterygium following primary pterygium excision and limbal conjunctival autograft surgery
Phase 2
- Conditions
- Health Condition 1: H110- Pterygium of eye
- Registration Number
- CTRI/2020/04/024498
- Lead Sponsor
- GURU NANAK EYE CENTRE MAMC AND ASSOCIATED HOSPITALS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS WITH PROGRESSIVE PTERYGIUM,HEAD OF PTERYGIUM ENCROACHING UPON THE PERIPHERAL CORNEA
Exclusion Criteria
1.RECURRENT PTERYGIUM
2.OCULAR SURFACE DISORDER INCLUDING DRY EYES AND MEIBOMIAN GLAND DYSFUNCTION
3.ANY EXTRAOCULAR SURGERY PAST 6 MONTHS
4.PREGNANT WOMEN
5.UNCONTROLLED SYSTEMIC DISEASES
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RECURRENCE OF PTERYGIUMTimepoint: THREE MONTHS
- Secondary Outcome Measures
Name Time Method COMPLICATIONS- LIKE SCLERAL MELTING, CORNEAL OPACIFICATION ETC.Timepoint: THREE MONTHS